Patent AT-E399795-T1: [Translated] METHOD FOR PRODUCING IMPROVED DEXTRAN-HEMOGLOBIN CONJUGATES

Description

An hemoglobin (Hb)-Dextran (Dx) conjugate having a molecular weight between 50 kd and 500 kD provides a blood substitute that results in acceptable erythrocyte sedimentation rate (ESR) and excretion rate (EXC) values. DxHb conjugates of the invention can be used for a variety of purposes as an alternative to blood.

Resources

Name Format Description Link
21 Access the complete Patent AT-E399795-T1: [Translated] METHOD FOR PRODUCING IMPROVED DEXTRAN-HEMOGLOBIN CONJUGATES on the official website. https://pubchem.ncbi.nlm.nih.gov/patent/AT-E399795-T1

Tags

  • patent
  • chemistry
  • research
  • innovation
  • pubchem

Topics

Categories